| Name: | Clindamycin phosphate EP Impurity C |
| Catalogue No. | VL1030003 |
| CAS No. | 28708-34-1 |
| Molecular Formula | C18H34ClN2O8PS |
| Molecular Weight | 505.0 g/mol |
| Status | In-stock |
| IUPAC Name | Methyl 7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propylpyrrolidin-2-yl]carbonyl]amino]-1-thio-L-threo-α-D-galacto-octopyranoside 3-(dihydrogen phosphate |
| Synonyms | Clindamycin-3-Phosphate |
| Appearance | White solid |
| Description | Clindamycin phosphate EP Impurity C (CAS No: 28708-34-1) or Clindamycin-3-Phosphate is a metabolite of Clindamycin. Clindamycin is a potent antimicrobial agent widely evaluated in the treatment of anaerobic infections. Clindamycin is useful in the treatment of most infections involving anaerobes and gram-positive cocci but due to its emerging resistance, some problems arise in some clinical domains. |
| References | Brown, Leo W. “High-Pressure Liquid Chromatographic Assays for Clindamycin, Clindamycin Phosphate, and Clindamycin Palmitate.” Journal of Pharmaceutical Sciences, vol. 67, no. 9, Sept. 1978, pp. 1254–57, https://doi.org/10.1002/jps.2600670917. Kasten, Mary Jo. “Clindamycin, Metronidazole, and Chloramphenicol.” Mayo Clinic Proceedings, vol. 74, no. 8, Aug. 1999, pp. 825–33, https://doi.org/10.4065/74.8.825. |
